Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 - Concepedia

Concepedia

Publication | Open Access

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

DOI Full Paper Access

57

Citations

25

References

2023

Year

Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis,

Annals of Oncology

Abstract

In HLA-A2-positive patients with advanced NSCLC and secondary resistance to immunotherapy, OSE2101 increased survival with better safety compared to CT. Further evaluation in this population is warranted.

References

	Year	Citations

Page 1